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LETTERS TO THE EDITOR
Correspondence to Seymour Rosen, M.D., Department of Pathology,Concerns about KIM-1 as a Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston,
MA 02215, USA.
E-mail: srosen@caregroup.harvard.eduurinary biomarker for acute
REFERENCEStubular necrosis (ATN)
1. Han WK, Bailly V, Abichandani R, et al: Kidney injury molecule-1
(KIM-1): A novel biomarker for human renal proximal tubule in-
To the Editor: In a recent issue of Kidney International, jury. Kidney Int 62:237–244, 2002
2. Rosen S, Heyman SN: Difficulties in understanding human “acuteHan et al [1], regarding kidney injury molecule-1 (KIM-1)
tubular necrosis”: Limited data and flawed animal models. Kidneyas a urinary biomarker for human proximal tubule injury,
Int 60:1220–1224, 2001brequires clarification. First, the selection of biopsied pa-
tients with putative acute tubular necrosis (ATN) is prob-
lematic. The authors include “ischemia” with minimal Calciphylaxis is usuallychange, interstitial nephritis, and membranous nephropa-
thy [with nonsteroidal anti-inflammatory drugs (NSAIDs)] nonulcerating: Risk factors,and state that all patients had a confirmed pathologic
diagnosis of ATN. Interstitial nephritis, membranous ne- outcomes, and therapyphropathy (with NSAIDs), and minimal change disease
are not commonly associated with ATN. Even in renal
To the Editor: The paper on calciphylaxis by Fine andbiopsies done within days after transplantation, changes
Zacharias [1] in a recent issue of Kidney International didof overt tubular necrosis are usually very limited [2].
not describe the exact histopathologic findings on skinSecond, the expression of KIM-1 in these patients’
biopsy of their patients. The sine qua non of the disorderbiopsies, as illustrated in Figure 1B of Han et al’s article,
is medial calcinosis of the small arteries in the subcutisis in the proximal convoluted tubules (S1/S2) not the
[2, 3]. Progression leads to acute infarction of the subcuta-pars recta (S3), the tubule in which KIM-1 has been
neous adipose tissue [4].demonstrated in experimental ischemia reflow [1]. Fur-
The relevance of bone scan remains unclear. The expe-thermore, there are no biopsy controls from patients that
rience of the authors indicated that in two of their totalthe authors did not consider to have ATN.
eight patients, there was no uptake in “clinically obviousThird, the control group for urinary KIM-1 concentra-
areas” but uptake was present in distant organs liketion was much younger than patients with ATN. The urine
lungs. Yet, the conclusion was that bone scan was “almostcollections occurred at various times in relationship to
always positive.” In a patient with retained subcutaneouspeak creatinine and levels of KIM-1 were “normalized”
tissue underlying the affected cutaneous area, would nofor this variation. Can one correct for incremental differ-
uptake on bone scan exclude a diagnosis of calciphylaxis?ences in KIM-1 excretion without extensive data concern-
The authors advocated against skin biopsy. In fact,ing the pattern of excretion of this protein? Interestingly,
skin biopsy was done only in four patients. Is it possiblethe patient who underwent repair of an aortic aneurysm
that some of the patients who responded to prednisone(represented in Figure 4 of Han et al’s article) had very
might have had another dermatologic disease?high levels of urinary KIM-1 without clinical ATN.
Finally, the patients considered to have contrast ne-
Prem K.G. Chandranphropathy have limited KIM-1 excretion consistent with
Des Moines, Iowa
the experimental contrast nephropathy model showing
predominantly distal nephron injury [2]. This under- Correspondence to Prem K.G. Chandran, M.D., Nephrology Clinic,
1215 Pleasant, #100, Des Moines, Iowa 50309.scores the limitation of KIM-1 as a marker for ATN that
E-mail: pkgchandran@mchsi.commay involve nephron segments other than the proximal
tubule.
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